Papers by Xiaodong Liu · AgingResearch.News

Nature Communications14 Sep
The efficacy, immunogenicity and safety of the LZ901 vaccine for herpes zoster virus in adults 40 years of age or older: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Trial in peopleInterventions
Paper
Nature Biotechnology8 Sep
Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment
Randomised trial in peopleBiomarkers
Paper
bioRxiv11 Aug
Virtual-cell verification enables self-auditing AI discovery for immune rejuvenation
Preprint: experiments in human cellsBlood and immune system
Paper
Annals of Surgery6 Aug
Parathyroidectomy Reduced the Risk of Incident Major Adverse Cardiovascular Events Among Patients With Primary Hyperparathyroidism-Results From a Population-Wide Target Trial Emulation Study
Study in peopleInterventions
Paper